3675 MARKET STREET, PHILADELPHIA, PA
News, Articles of Incorporation, Bylaws
Other Events
Amicus Therapeutics Special Meeting Approves Merger and Compensation Proposals
Announces Full-Year 2025 Financial Results and Corporate Updates
Earnings Release
Enters Definitive Agreement to be Acquired for $14.50 per Share in Cash, Investor Presentation
Announces Third Quarter 2025 Financial Results and Corporate Updates
Investor Presentation
FY 2024
Q3
Q2
Q1
FY 2023
Notice of Suspension of Duty to File Reports
Effectiveness Notice
Additional Proxy Materials
Definitive Merger Proxy Statement
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Notification Filed by a National Security Exchange
Statement of Changes in Beneficial Ownership
S-8 POS
Automatic Shelf Registration Statement